Donor Type Does Not Impact Late Graft Failure Following Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis. - Hickey CL; Zhang MJ; Allbee-Johnson M; Romee R; Majhail NS; Malki MMA; Antin JH; Benjamin CL; Bredeson C; Chhabra S; Grunwald MR; Inamoto Y; et al. (Transplantation and cellular therapy, 2025)